| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,834 |
10,474 |
$639K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,567 |
6,755 |
$637K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,129 |
3,128 |
$316K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,853 |
2,897 |
$261K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,108 |
1,646 |
$157K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,516 |
5,168 |
$106K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,886 |
2,334 |
$100K |
| 90671 |
|
727 |
576 |
$62K |
| 96127 |
|
3,471 |
2,835 |
$58K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
561 |
523 |
$47K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,833 |
1,528 |
$43K |
| 90686 |
|
3,237 |
2,842 |
$41K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
936 |
624 |
$38K |
| 90670 |
|
2,394 |
1,794 |
$38K |
| D1206 |
Topical application of fluoride varnish |
1,278 |
971 |
$33K |
| 90651 |
|
606 |
552 |
$30K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,373 |
1,194 |
$29K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,755 |
1,528 |
$27K |
| 90698 |
|
2,210 |
1,671 |
$23K |
| 90633 |
|
1,965 |
1,533 |
$22K |
| 83655 |
|
1,924 |
1,465 |
$22K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,501 |
1,339 |
$19K |
| 90680 |
|
1,685 |
1,247 |
$17K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
220 |
150 |
$14K |
| 99174 |
|
1,587 |
1,287 |
$12K |
| 99173 |
|
1,511 |
1,331 |
$11K |
| 90710 |
|
666 |
500 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
142 |
107 |
$9K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
112 |
66 |
$9K |
| 36416 |
|
2,028 |
1,587 |
$8K |
| 90697 |
|
463 |
379 |
$8K |
| 90649 |
|
390 |
290 |
$8K |
| 90734 |
|
464 |
330 |
$7K |
| 87631 |
|
70 |
49 |
$7K |
| 90715 |
|
347 |
271 |
$5K |
| 90744 |
|
688 |
562 |
$5K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
19 |
15 |
$4K |
| 85018 |
|
1,842 |
1,410 |
$4K |
| 87807 |
|
403 |
359 |
$4K |
| 90619 |
|
187 |
174 |
$3K |
| 90696 |
|
256 |
187 |
$3K |
| 90681 |
|
144 |
129 |
$2K |
| 90685 |
|
251 |
182 |
$2K |
| 90621 |
|
80 |
63 |
$2K |
| 99215 |
Prolong outpt/office vis |
15 |
15 |
$1K |
| 90716 |
|
101 |
76 |
$1K |
| 99381 |
|
15 |
13 |
$1K |
| 90707 |
|
88 |
64 |
$1K |
| 90620 |
|
31 |
28 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
20 |
20 |
$955.40 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
46 |
44 |
$898.80 |
| 90672 |
|
48 |
43 |
$777.07 |
| 90381 |
|
41 |
35 |
$685.11 |
| 90648 |
|
74 |
64 |
$623.14 |
| 90723 |
|
39 |
32 |
$550.95 |
| 81003 |
|
27 |
27 |
$56.68 |
| 99072 |
|
15 |
14 |
$0.00 |